Volume 60, Issue 6, Pages (December 2001)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

The flux of arginine after ischemia-reperfusion in the rat kidney
Volume 61, Issue 4, Pages (April 2002)
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
Inflammatory cytokines in acute renal failure
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Plasma sodium and hypertension
Volume 64, Issue 5, Pages (November 2003)
Volume 67, Issue 5, Pages (May 2005)
Volume 78, Issue 11, Pages (December 2010)
Volume 79, Issue 1, Pages (January 2011)
Volume 59, Issue 5, Pages (May 2001)
Volume 68, Issue 6, Pages (December 2005)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Furosemide stimulates macula densa cyclooxygenase-2 expression in rats
Volume 84, Issue 3, Pages (September 2013)
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
The Case ∣ Acute renal failure and anemia
Volume 65, Issue 2, Pages (February 2004)
Volume 78, Issue 10, Pages (November 2010)
Volume 64, Issue 5, Pages (November 2003)
Volume 63, Issue 3, Pages (March 2003)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 61, Issue 2, (February 2002)
Volume 75, Issue 3, Pages (February 2009)
Actin cytoskeleton in ischemic acute renal failure
Volume 54, Issue 5, Pages (November 1998)
Volume 64, Issue 1, Pages (July 2003)
Volume 79, Issue 1, Pages (January 2011)
Vikas Chander, PhD, Kanwaljit Chopra, PhD  Journal of Vascular Surgery 
Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure  Christos P. Carvounis, Sabeeha Nisar, Samerah Guro-Razuman 
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 67, Issue 6, Pages (June 2005)
Volume 61, Issue 3, Pages (March 2002)
Volume 61, Issue 2, Pages (February 2002)
Volume 64, Issue 5, Pages (November 2003)
Volume 66, Issue 2, Pages (August 2004)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 82, Issue 3, Pages (August 2012)
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Volume 68, Issue 4, Pages (October 2005)
Volume 66, Issue 6, Pages (December 2004)
Volume 73, Issue 12, Pages (June 2008)
Volume 65, Issue 3, Pages (March 2004)
Volume 68, Issue 1, Pages (July 2005)
Volume 56, Issue 3, Pages (September 1999)
Volume 63, Issue 5, Pages (May 2003)
Volume 61, Issue 4, Pages (April 2002)
Volume 60, Issue 6, Pages (December 2001)
20-HETE in acute kidney injury
Volume 66, Issue 4, Pages (October 2004)
Volume 79, Issue 2, Pages (January 2011)
Volume 67, Issue 6, Pages (June 2005)
Volume 74, Issue 1, Pages (July 2008)
Volume 56, Issue 5, Pages (November 1999)
Volume 73, Issue 3, Pages (February 2008)
Andrea Schreiber, Franziska Theilig, Frank Schweda, Klaus Höcherl 
Volume 60, Issue 6, Pages (December 2001)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Volume 67, Issue 4, Pages (April 2005)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Silvia B. Campos, Lucia H.K. Rouch, Antonio C. Seguro 
Volume 60, Issue 3, Pages (September 2001)
Volume 58, Issue 5, Pages (November 2000)
Volume 60, Issue 3, Pages (September 2001)
E. Homsi, P. Janino, J.B.L. de Faria  Kidney International 
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Alex B. Magil, Kathryn Tinckam  Kidney International 
Volume 54, Issue 2, Pages (August 1998)
Presentation transcript:

Volume 60, Issue 6, Pages 2283-2289 (December 2001) S3226, a novel NHE3 inhibitor, attenuates ischemia-induced acute renal failure in rats  Dr Max Hropot, Hans-Paul Juretschke, Karl Heinz Langer, Jan-Robert Schwark  Kidney International  Volume 60, Issue 6, Pages 2283-2289 (December 2001) DOI: 10.1046/j.1523-1755.2001.00058.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Effects of intravenous infusion of S3226 in acute renal failure (ARF) on plasma creatinine (A), blood urea nitrogen (BUN; B), sodium (C) and potassium (D). Renal arteries were occluded for 40 minutes. S3226 was infused for 30 minutes before ischemia (; N = 12) or after release of clamps (; N = 12) at a dose of 20 mg/kg. Control rats received saline in a volume of 6.25 mL/kg (; N = 12). Values are means ± SEM, *P < 0.05 vs. control group. Kidney International 2001 60, 2283-2289DOI: (10.1046/j.1523-1755.2001.00058.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Effects of intravenous infusion of S3226 in acute renal failure (ARF) on plasma creatinine (A), blood urea nitrogen (BUN; B), sodium (C) and potassium (D). Renal arteries were occluded for 40 minutes. S3226 was infused for 30 minutes before ischemia (; N = 12) or after release of clamps (; N = 12) at a dose of 20 mg/kg. Control rats received saline in a volume of 6.25 mL/kg (; N = 12). Values are means ± SEM, *P < 0.05 vs. control group. Kidney International 2001 60, 2283-2289DOI: (10.1046/j.1523-1755.2001.00058.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Effect of S3226 on renal intracellular pH of fasted uninephrectomized rats as monitored by in vivo 31P NMR spectroscopy. The drug was infused twice to maintain suitable blood levels as indicated in the labeled boxes at a dose of 20 mg/kg over 30 minutes. (A) S3226 did not affect pHi during normoxia (N = 4 each group). (B) S3226 was infused prior to and 5 minutes before ending of ischemia. In the S3226 group (N = 8 for each group) pHi was significantly reduced by 0.15 units (P < 0.05) during the 5-hour reperfusion period. Values are means ± SEM. Symbols are: (●) control, (□) drug. *P < 0.05 vs. control group. Kidney International 2001 60, 2283-2289DOI: (10.1046/j.1523-1755.2001.00058.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Overview of the kidney cortex from a control (A) and a treated (B) rat. In panel A, tubular single or group necrosis (often extruded into the lumen), tubular dilation and diffusely distributed round cell infiltration in a broadened interstitium are visible, but these lesions are not observed in panel B. PAS staining, magnification ×160. Kidney International 2001 60, 2283-2289DOI: (10.1046/j.1523-1755.2001.00058.x) Copyright © 2001 International Society of Nephrology Terms and Conditions